The data is a step toward a vaccine for infants, toddlers and children younger than 5 — the last age group to lack access to a coronavirus vaccine in the United States.
The two-shot coronavirus vaccine provoked immune responses similar to those of the adult vaccine but was modestly protective against the omicron variant.
Sobered by the way the omicron variant tore through the population — including the vaccinated — some scientists think the next coronavirus vaccine should be a spray up the nose.